Elm Mix Allergy Shots: Spring vs Fall Ulmus Exposure
Elm mix is the polyspecific SCIT blend prescribed when a patient reports elm allergy but the panel does not distinguish species. The critical clinical variable is season: American elm sheds February–April while cedar and Chinese elm shed August–November — and the wrong mix can under-dose whichever species drives your symptoms. No IUIS-named Ulmus allergen exists and no SCIT RCT has been published for any elm species.
About Curex’s SCIT program
Curex’s at-home allergy shots (SCIT) are coming soon and focus on the most common environmental allergens:
- • Pollens — tree, grass, weed & ragweed
- • Pet dander — cat & dog
- • Dust mites
- • Molds — Alternaria & mold mix
Elm Mixis covered here for general education and may not be part of Curex’s current treatment set. Join the waitlist and our care team will help confirm your options.
Elm Mix Allergy Immunotherapy: How It Works
Allergy immunotherapy is the only long-term treatment that re-trains the immune system to stop overreacting to elm mix — rather than just masking symptoms with antihistamines or steroids. By gradually exposing the body to controlled doses of elm mix allergen, immunotherapy shifts the underlying allergic response and produces relief that often outlasts treatment by 7–10 years.
There are two evidence-based forms of elm mix immunotherapy used today, both built on the same desensitization principle but delivered very differently.
of sustained relief after a complete immunotherapy course — the only allergy treatment with proven long-term effect after stopping.
Allergy Shots (SCIT)
Weekly injections of elm mix extract in a clinic, escalating over 3–6 months until a maintenance dose is reached. Continued monthly for 3–5 years. Longest clinical track record for elm mix allergy.
- Strongest evidence base for severe and polysensitized patients
- Covered by most insurance plans
- Requires 50–100+ in-person clinic visits across the full course
- Or at home with no clinic visits— Curex’s Virtual Shot Room model delivers the same SCIT program with live video supervision by trained Curex clinical staff for the first injection from each new vial or concentration and restarts after gaps or reactions.
Allergy Drops / Tablets (SLIT)
Daily drops or dissolvable tablets containing elm mix extract, held under the tongue at home. Same desensitization principle, delivered without injections. WHO-recognized as an effective form of allergy immunotherapy since 2001.
- Taken at home — no weekly clinic trips, no needles
- Lower systemic reaction rate than allergy shots
- Curex offers prescription elm mix immunotherapy drops with allergist oversight
The rest of this page goes deep on allergen-specific immunotherapy with shots — protocol, efficacy data, side effects, and cost. If you’d rather skip the clinic and treat elm mix allergy with at-home drops, see how Curex sublingual immunotherapy compares below.
What is Elm Mix?
The biology, taxonomy, and clinical fingerprint of Elm Mix — the foundation of how SCIT targets it.
Elm pollen is 23–38 µm, oblate-stephanoporate with 5–6 pores — shed in massive quantities from bare branches before leaf emergence.
- Scientific name
- Ulmus spp. (mixed)
- Family
- UlmaceaeElm family
- Type
- Tree pollen — wind-pollinated deciduous mix
- Native to
- North America, Asia (naturalized U. parvifolia)
- Allergen proteins
- No formally named IUIS allergen for any Ulmus species as of May 2026
- Particle size
- 23–38 µm equatorial diameter, oblate, stephanoporate (5–6 pores)
- Avoidance difficulty
- Very difficult
How Elm Mix Allergy Presents
Symptoms by body system — useful for distinguishing Elm Mix sensitivity from overlapping allergies and infections.
Respiratory
- Sneezing triggered by outdoor exposure during elm pollen peak
- Nasal congestion and rhinorrhea during spring or fall elm season
- Post-nasal drip worsening at night during high-count days
- Exacerbation of allergic asthma coinciding with Ulmus pollen counts
- Throat irritation and mild cough from inhaled pollen
Ocular
- Watery, itchy eyes during elm pollen season
- Conjunctival redness and puffiness on high-count outdoor days
- Eye symptoms preceding nasal symptoms in some patients
- Contact lens intolerance during elm season
Dermal
- Worsening of atopic dermatitis coinciding with spring or fall elm season
- Contact urticaria from direct pollen skin exposure (uncommon)
- Facial flushing in highly sensitized individuals on extreme-count days
Systemic
- Fatigue and reduced concentration during peak pollen load
- Sleep disruption due to nasal congestion during elm season
- Generalized malaise in patients with multiple concurrent spring sensitizations
- Headache from prolonged sinus congestion
When a patient says 'elm allergy,' I always ask: do you flare in March, or in October? That single question separates American elm spring exposure from cedar elm fall exposure — and it changes the prescription mix more than any IgE panel result ever could.
When & Where Elm Mix Peaks
Allergen intensity by month and by state. Useful for timing SCIT start dates and travel planning.
12-Month Intensity
Double peak: American elm February–April (Eastern US) and cedar/Chinese elm September–October (South-Central/Gulf states)· Spring peak lasts 6–10 weeks; fall peak lasts 8–12 weeks for cedar and Chinese elm
US Exposure Map
10 high-intensity statesExposure intensity by state (text version)
- ME:
- Low
- VT:
- Low
- NH:
- Low
- WA:
- Low
- MT:
- Low
- ND:
- Low
- MN:
- Low
- WI:
- Low
- MI:
- Low
- NY:
- Moderate
- MA:
- Low
- OR:
- Low
- ID:
- Low
- WY:
- Low
- SD:
- Low
- IA:
- Moderate
- IL:
- Moderate
- IN:
- High
- OH:
- High
- PA:
- Moderate
- NJ:
- Moderate
- CT:
- Low
- RI:
- Low
- CA:
- Low
- NV:
- Low
- UT:
- Low
- CO:
- Low
- NE:
- Moderate
- MO:
- Moderate
- KY:
- High
- WV:
- Moderate
- VA:
- Moderate
- MD:
- Moderate
- DE:
- Moderate
- AZ:
- Low
- NM:
- Low
- KS:
- Moderate
- AR:
- High
- TN:
- High
- NC:
- Moderate
- SC:
- Moderate
- OK:
- High
- LA:
- High
- MS:
- High
- AL:
- High
- GA:
- Moderate
- TX:
- High
- FL:
- Moderate
- AK:
- Low
- HI:
- Low
What Elm Mix Cross-Reacts With
Patients sensitized to one allergen often react to others sharing similar proteins. This map shows the documented molecular overlaps.
Elm mix cross-reactivity is largely confined to the Ulmaceae family — molecular studies show little cross-reactivity between elms and other tree families such as Fagales or Oleaceae.
Is SCIT Right for Your Elm Mix Allergy?
Answer five questions to gauge whether elm mix allergy shots are likely to benefit your symptom profile.
How severe are your elm pollen symptoms at peak season?
The Elm Mix SCIT Protocol
Elm mix SCIT follows the standard non-standardized inhalant extract protocol, with extract potency adjusted individually because no FDA-standardized elm extract exists.
The allergist titrates from very dilute starting concentrations up to the target maintenance dose, increasing the elm pollen protein load at each visit. The 30-minute post-injection observation period is mandatory at every build-up visit to detect any systemic reaction promptly.
Once the target maintenance dose is reached, the interval extends to maintenance injections. Patients continue to self-monitor for 30 minutes after each injection with a prescribed epinephrine auto-injector on hand, and any dose change is supervised live in the Virtual Shot Room by trained Curex clinical staff. The timing of the maintenance phase can be coordinated around the spring and fall elm pollen peaks for optimal immunologic benefit.
After completing the recommended course, many patients enjoy durable symptom relief that outlasts the injection period — studies of non-standardized tree SCIT suggest post-treatment benefit lasting 7 or more years (Cox 2011 Practice Parameter).
Extract Concentration Ladder
You progress through each vial during build-up. Concentration increases ~10x per step.
What the Research Shows for Elm Mix SCIT
No SCIT-specific randomized controlled trial has been published for any Ulmus species. Clinical evidence is extrapolated from broader tree-pollen SCIT practice parameters and observational data linking Ulmus pollen counts to respiratory outcomes.
- Ulmus pollen–asthma hospitalization correlation55%Dales et al., Int Arch Allergy Immunol 2008;146:241–247 — Canadian cities study
- US patient sensitization to elm pollen25%Hoffman, cited in Ann Allergy Asthma Immunol 2014 Chinese Elm allergen-of-the-month; 371-patient US series
- General non-standardized tree SCIT symptomatic benefit (extrapolated)50%Cox L et al., J Allergy Clin Immunol 2011;127:S1–S55 — Practice Parameter Third Update
Elm mix SCIT lacks dedicated RCT evidence. The practice parameter framework (Cox 2011; Greenhawt 2023) supports its use in patients with confirmed sensitization and inadequate pharmacotherapy response, extrapolating principles from better-studied tree pollens. A board-certified allergist can confirm whether your elm sensitization profile supports a mix prescription or a species-targeted approach.
Ready to skip the surprise bills?
At-home allergy shots (SCIT) are designed by board-certified allergists. See the listed SCIT plan rate in our pricing record and request a quote for eligibility, initiation and total care costs.
- MD-ledBoard-certified allergists
- QuoteTotal care estimate
- 50K+Patients treated
- HSA/FSAEligible
Elm Mix SCIT Side Effects
Elm mix SCIT side effects follow the pattern for non-standardized inhalant tree extracts, with local injection-site reactions being most common and severe systemic events rare.
Local reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Injection-site swelling Erythema and induration at injection site; typically resolves within hours | Rate 25–50% | Mild |
Injection-site itching Pruritus at the injection site; cold compresses provide relief | Rate 20–40% | Mild |
Large local reaction Swelling >5 cm at injection site; may require dose adjustment at next visit | Rate 5–10% | Moderate |
Delayed local reaction Soreness or induration appearing 4–8 hours after injection | Rate 5–8% | Mild |
Systemic reactions
4 documented| Reaction | Rate | Severity |
|---|---|---|
Rhinitis or conjunctivitis flare Transient nasal or eye symptoms after injection; usually resolves spontaneously | Rate 0.5–1% | Mild |
Generalized urticaria Hives beyond the injection site; requires prompt evaluation — at-home Curex patients reach the care team by message, and changes to a new vial or concentration is supervised live in the Virtual Shot Room by trained Curex clinical staff. | Rate 0.1–0.3% | Moderate |
Mild asthma exacerbation Bronchospasm after injection; patients with active asthma require pre-injection lung function check | Rate 0.1–0.2% | Moderate |
Anaphylaxis Systemic anaphylaxis is rare with proper dosing protocols; a 30-minute self-observation, a prescribed epinephrine auto-injector confirmed on hand, and live Zoom supervision of the first injection from each new vial or concentration make safe at-home administration possible for eligible patients. | Rate <0.01% | Severe |
SCIT has traditionally been given in a clinic equipped for emergency treatment; for eligible patients, Curex makes safe at-home self-administration possible with a personalized serum sterile-compounded to USP <797>, a prescribed epinephrine auto-injector confirmed on hand, and the first injection from each new vial or concentration supervised live in the Virtual Shot Room. A 30-minute observation accompanies each dose and is associated with a significant reduction in serious systemic events (Cox 2011 Practice Parameter).
SCIT vs Alternatives for Elm Mix
Elm mix allergy management options range from daily medications through to SCIT; the best approach depends on symptom severity, season length, and patient ability to attend weekly clinic visits.
| Criterion | SCITBest | SLIT | Avoidance | Medications |
|---|---|---|---|---|
| Effectiveness | Moderate (no RCT) | Comparable (extrapolated) | Partial only | Good symptom control |
| 5-yr cost | $3,500–$8,000 | Varies by provider; not the Curex product | Low | $500–$2,000/yr |
| Duration | 3–5 years | 3–5 years | Ongoing | Lifelong |
| Convenience | At-home build-up then ongoing maintenance with Curex | Daily drops at home | Difficult — outdoor pollen | Daily pill/spray |
| Safety | Very safe; USP <797> serum with Virtual Shot Room–supervised dosing | Very safe | Excellent | Generally safe |
| Lasting effect | Yes, years post-tx | Yes, years post-tx | No | No — returns off meds |
SCITBest
SLIT
Avoidance
Medications
Immunotherapy offers a prospect of durable disease modification for elm-sensitized patients with multi-year symptoms. Both subcutaneous (SCIT) and sublingual (SLIT) immunotherapy are effective and generally safe; the right choice depends on the patient's lifestyle and preferences. With Curex, eligible patients can self-administer SCIT at home with pricing confirmed in a current program quote instead of attending weekly clinic visits, with the first injection from each new vial or concentration supervised live in the Virtual Shot Room and a prescribed epinephrine auto-injector confirmed on hand.
What Elm Mix SCIT Actually Costs
Most major US insurers cover elm SCIT under standard allergy benefits when ordered by a board-certified allergist and supported by documented positive elm sensitization testing; out-of-pocket costs depend on deductible, co-insurance, and whether the extract preparation fee is bundled. Curex at-home IgE testing identifies specific elm mix sensitization before allergist consultations, eliminating the need for an initial skin-test visit.
Cost range varies by deductible, co-insurance, and clinic.
Verify these codes with your insurer to confirm coverage.
See the listed Environmental Allergy Shots Plan rate, commercial terms dated 2026-10-12; consultations are included without copay. Confirm availability, eligibility, other included services, testing, any in-person care, insurance responsibility and billing cadence in your written quote before enrolling.
Join the waitlistStop guessing about your elm mix allergy. Get a plan.
Take Curex’s 3-minute allergy quiz. A board-certified allergist will review your symptoms and recommend the right immunotherapy path for you — shots or drops.
Free quiz · Board-certified allergists · 50,000+ patients treated · HSA/FSA eligible
Elm Mix SCIT — Frequently Asked
Quick answers to the questions patients ask most before starting treatment.
Elm mix is a polyspecific Ulmus extract typically combining American elm (Ulmus americana), Chinese elm (Ulmus parvifolia), and sometimes cedar elm (Ulmus crassifolia) in a single injectable preparation. It is used when a patient reports elm allergy but species-specific testing has not been done — or when clinical history suggests exposure to multiple elm species. Because no FDA-standardized elm extract exists, the proportions and potency vary by manufacturer. The critical clinical issue is that American elm pollinates in spring (February–April) while Chinese and cedar elm pollinate in fall (August–November), so one mix cannot optimally target both peaks simultaneously. A board-certified allergist can review whether your exposure pattern calls for a species-targeted approach instead.
Most patients report meaningful symptom improvement after 6–12 months of elm SCIT — typically toward the end of the build-up phase or early in the maintenance phase. The most substantial benefit usually appears after 12–24 months of treatment. Because no elm-specific randomized controlled trial has been published, these timelines are extrapolated from broader non-standardized tree SCIT data (Cox 2011 JACI Practice Parameter). Some patients notice early improvement within the first elm season after starting treatment; others require two full seasons before symptoms substantially decrease. Consistent adherence to the injection schedule is the most important factor determining how quickly benefit appears.
Antihistamines may be continued during elm SCIT in most cases, and many allergists encourage their use for breakthrough symptoms during the build-up phase. However, some protocols ask patients to avoid antihistamines in the 24 hours before an injection, because antihistamines can partially mask early signs of a systemic reaction during the 30-minute post-injection observation period. Your allergist will provide specific guidance on medication use around injection days. Intranasal corticosteroid sprays are generally safe to continue throughout the SCIT course and are often recommended as adjunct therapy during elm pollen peaks.
The spring and fall pollination seasons of different elm species mean that a patient flaring in October likely has a cedar or Chinese elm sensitization — not American elm — and prescribing a mix weighted toward American elm risks under-dosing the actual offender. Conversely, a spring-only patient may be getting unnecessary cedar elm extract in every injection. A 24.6% sensitization rate to elm in US patients (Hoffman, Ann Allergy Asthma Immunol 2014) confirms elm is a real clinical driver, but the sensitization profile varies by region. Species-specific ImmunoCAP or skin-prick testing to each elm species before prescribing helps your allergist build a prescription that targets your actual exposure — rather than defaulting to a broad mix.
Missing one injection during the build-up phase typically requires the allergist to reduce the next dose and potentially repeat a previous concentration level, extending the build-up timeline. During the maintenance phase, gaps of 4–8 weeks are usually manageable without dose reduction, but gaps beyond 8 weeks may require restarting at a lower dose. The specific missed-dose protocol depends on how long the gap is and where you are in the treatment course — your clinic will have a written policy for this. Call your allergist's office as soon as possible after a missed appointment; never attempt to skip ahead to where you left off without clinical guidance, as that increases the risk of a systemic reaction.
Most major US health insurers cover elm SCIT under standard allergy benefits when it is ordered by a board-certified allergist and supported by documented positive sensitization testing (skin-prick or specific IgE). Coverage requires a diagnosis code consistent with allergic rhinitis or allergic asthma triggered by tree pollen. Out-of-pocket costs depend on your plan's deductible and co-insurance — over a 5-year course, patient costs typically range from $3,500 to $10,000 after insurance. The CPT codes most commonly used are 95115 (injection only) and 95165 (extract preparation). Prior authorization is frequently required; your allergist's billing office can assist with this process.
Elm mix SCIT (injections) and sublingual immunotherapy (SLIT drops) both aim to desensitize the immune system to Ulmus pollen. No head-to-head randomized trial comparing elm SCIT to elm SLIT has been published in US patients; both are administered with non-standardized elm extracts. SCIT requires weekly clinic visits for approximately 6 months during build-up, then ongoing maintenance injections, while SLIT drops are taken daily at home. The convenience advantage of SLIT is significant for patients who travel frequently or live far from an allergy clinic. A board-certified allergist can review your sensitization pattern and symptom severity to determine which delivery method is more appropriate for your clinical situation.
Elm SCIT is routinely used in pediatric patients with confirmed elm sensitization and inadequate symptom control on pharmacotherapy. The AAAAI/ACAAI Practice Parameters support allergen immunotherapy in children as young as 5 years, though individual age cutoffs vary by practice. Pediatric elm SCIT follows the same non-standardized build-up and maintenance protocol as adult treatment, with starting doses and escalation rates adjusted for body weight and skin-test reactivity. The mandatory 30-minute observation period after each injection is especially important in children, and parents should be instructed in early systemic reaction recognition. A large safety study of self-administered allergen immunotherapy (Schaffer et al., 2015) found that across 23,614 patients giving 2,021,600 injections the systemic reaction rate was just 0.16% per patient with no fatalities — lower than the 3%–14% typically seen with office-based shots. A board-certified pediatric allergist can assess whether your child's symptom burden and sensitization profile support elm SCIT.
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.
Questions about Curex itself?
Straight answers about the company, the evidence, what patients report, and what it costs — including the parts that are not flattering.